Nearly half of the patients were never smokers (n = 340, 45.3%), had normal weight (n = 338, 45.1%), stage IV disease (n = 353, 47.0%), emphysema (n = 335, 44.7%) and increased CEA level (n = 324, 43.2%). The gene discussed is CEACAM5; the disease is pulmonary emphysema.